Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective study
Seiya Ohtani(Keio University), Tsubasa Takizawa(Keio University), Nobuyuki Takahashi(Keio University Hospital), Jin Nakahara(Keio University Hospital), Keiko Ihara(Keio University), Naoki Miyazaki(Keio University Hospital), Narumi Watanabe(Keio University Hospital), Satoko Hori(Keio University), Ryo Takemura(Keio University Hospital), Kei Ishizuchi(Keio University Hospital)
Cited by 15
Related Papers
Hallmarks of primary headache: part 1 – migraine
|The Journal of Headache and Pain|2024|174
Spreading depolarizations trigger caveolin‐1–dependent endothelial transcytosis
|Annals of Neurology|2018|107
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
|Cephalalgia|2024|107
International Headache Society global practice recommendations for the acute pharmacological treatment of migraine
|Cephalalgia|2024|106
Spreading depression as a preclinical model of migraine
|The Journal of Headache and Pain|2019|104